Results 171 to 180 of about 9,385,653 (364)

Psychological impact of the COVID-19 pandemic on health care workers

, 2020
Amal M. Qasem Surrati, Farah Asad Mansuri, Abeer A. Ayadh Alihabi   +2 more
openalex   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Standardising personalised diabetes care across European health settings: A person‐centred outcome set agreed in a multinational Delphi study

, 2023
Ann‐Kristin Porth, Anouk S. Huberts, Alizé A. Rogge, Angèle H.M. Bénard, Angus Forbes, Anja Strootker, Carmen Hurtado del Pozo, Dagmar Kownatka, David Hopkins, David Nathanson, Henk‐Jan Aanstoot, Jeanette Soderberg, Katarina Eeg‐Olofsson, Kathryn Hamilton, Laure Delbecque, Lyudmil Ninov, Mette Due‐Christensen, Michael Leutner, Rafael Simó, Sara Vikstrom‐Greve, S Rössner, Vanesa Flores, Yuki Seidler, Yvonne Hasler, Tanja Stamm, Alexandra Kautzky‐Willer   +25 more
openalex   +1 more source

Health care costs [PDF]

Nature Medicine, 1996
openaire   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Health indicator recording in UK primary care electronic health records: key implications for handling missing data

Clinical Epidemiology, 2019
Irene Petersen,1,2 Catherine A Welch,3 Irwin Nazareth,1 Kate Walters,1 Louise Marston,1 Richard W Morris,4 James R Carpenter,5,6 Tim P Morris,5 Tra My Pham1 1Department of Primary Care and Population Health, University College London, London NW3 2PF, UK;
Petersen I, Welch CA, Nazareth I, Walters K, Marston L, Morris RW, Carpenter JR, Morris TP, Pham TM   +8 more
doaj  

Clinical pharmacology in health care, teaching and research [PDF]

, 2013
M. D. Rawlins
openalex   +1 more source

Selective contracting and foreclosure in health care markets [PDF]

This paper provides an analysis of exclusive contracts between health care providers and insurers in a model where some consumers choose to stay uninsured.
Gijsbert Zwart, Jan Boone, Michiel Bijlsma   +2 more
core  

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source